NATHBIOGEN · Nath Bio-Genes (India) Ltd · Crops
NATHBIOGEN · Nath Bio-Genes (India) Ltd · Crops
As of 06 Nov close
52-week range
32.6% below 52-week high
52-week range: as of 06 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 16 Oct 2026
Revenue (latest Q)
₹328 Cr
Revenue YoY
PAT YoY
+14.1%
Operating margin
Revenue, last 5 quarters
Source: Yahoo Finance, as of 30 Jun 2026
P/E (TTM)
P/B
0.4
P/S (TTM)
Not available from data source
Sector P/E
Not available from data source
Dividend yield
+1.5%
Source: Yahoo Finance, as of 29 Oct 2026
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| NATHBIOGEN (this stock) | 7.2 | 0.4 | +7.5% | +4.8% | 0.2 | +1.5% |
| Kaveri Seed Company | 13.6 | 2.3 | Not available from data source | Not available from data source | Not available from data source | Not available from data source |
| Amir Chand Jagdish Kumar (Exports) Ltd | 16.4 | 2.3 | Not available from data source | Not available from data source | Not available from data source | Not available from data source |
| Andrew Yule & Company Ltd | Not available from data source | 4 | Not available from data source | Not available from data source | Not available from data source | Not available from data source |
Promoter
stable
FII
stable
MF
0.01% (0.00pp)
stable
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
AI Summary of Annual Report
AI-generatedThe report outlines Nath Bio-Genes' FY2025-26 performance, highlighting a 19% revenue increase and strong operational growth. Management emphasized strategic investments in R&D, distribution, and international expansion, while maintaining a focus on asset-light infrastructure. The company's diversified crop portfolio and geographic reach are positioned to mitigate risks from monsoon variability and geopolitical events. Corporate governance practices and internal controls were reinforced, with the Board's performance evaluated and governance structures updated to ensure compliance and transparency.
- Strategic focus on R&D, distribution expansion, and international growth, particularly in Uzbekistan.
- Diversified crop and geographic portfolio to mitigate monsoon and geopolitical risks.
- Strengthened corporate governance with Board evaluations and updated internal controls.
- Asset-light strategy with leased infrastructure to minimize capital expenditure.
- Commitment to maintaining high standards of transparency and compliance with regulatory requirements.
Key takeaway: Nath Bio-Genes is leveraging strategic diversification, R&D investment, and strong governance to navigate global and domestic challenges while maintaining growth in the Indian seed industry.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
No item of a kind that needs attention was stored for this company.
Contingent Liability
1 occurrenceEarlier (1-3 years ago)
The company has contingent liabilities not provided for, including claims from legal cases and corporate guarantees given to IDBI Bank.
Related-Party Transaction
1 occurrenceEarlier (1-3 years ago)
The company has disclosed transactions with related parties, including loans, advances, interest income, and share investments with entities such as Global Transgenes Ltd., Agri Tech (India) Ltd., and Paithan Mega Food Park Pvt Ltd., as part of its related parties disclosure.
Promoter Share Pledge
1 occurrenceRecent (last 12 months)
19.8% of promoter holding pledged (quarter 2026-Q3 as of 2026-07-18).